These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11225942)

  • 1. Detection of ventricular fibrillation in implantable defibrillators with automatic gain control amplifiers: effects of programming sensitivity.
    Schulte B; Sperzel J; Schwarz T; Pitschner HF; Strupp G; Neuzner J
    Europace; 2000 Apr; 2(2):160-2. PubMed ID: 11225942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
    Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
    Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site.
    Fetter JG; Benditt DG; Stanton MS
    J Am Coll Cardiol; 1996 Aug; 28(2):423-7. PubMed ID: 8800120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
    Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
    Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. True bipolar defibrillator leads have increased sensing latency and threshold compared with the integrated bipolar configuration.
    Frain BH; Ellison KE; Michaud GF; Koo CH; Buxton AE; Kirk MM
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):192-5. PubMed ID: 17239139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvenous pectoral implantation of single lead implantable cardioverter defibrillator.
    Wang F; Hua W; Chen X
    Chin Med J (Engl); 1999 Jan; 112(1):22-4. PubMed ID: 11593633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True bipolar and integrated bipolar sensing and detection by implantable defibrillators.
    Verga TA; Gillberg JM; Greenberg RM; Deger FT
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1561-8. PubMed ID: 21797907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective left ventricular sensing lead implantation to overcome undersensing of ventricular fibrillation during implantable cardioverter defibrillator implantation.
    Steinberg C; Philippon F; O'Hara G; Molin F
    Can J Cardiol; 2013 Jun; 29(6):751.e3-6. PubMed ID: 23395280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cautery-induced electromagnetic interference of cardiac implantable electrical devices by closely spaced bipolar sensing.
    Suresh M; Benditt DG; Gold B; Joshi GP; Lurie KG
    Anesth Analg; 2011 Jun; 112(6):1358-61. PubMed ID: 21543788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled clinical trial comparing ventricular fibrillation detection time between two transvenous defibrillator models. The Acute Ventak AV investigator group.
    Kühlkamp V; Mortensen P; Kirstein P; den Dulk K; Hoffman E; Wilber D; Higgins S; Kühl M
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):990-8. PubMed ID: 10456626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient alert in implantable cardioverter defibrillators: toy or tool?
    Becker R; Ruf-Richter J; Senges-Becker JC; Bauer A; Weretka S; Voss F; Katus HA; Schoels W
    J Am Coll Cardiol; 2004 Jul; 44(1):95-8. PubMed ID: 15234415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.